Baxter shares dented by HemAssist data demand
This article was originally published in Clinica
Executive Summary
Despite the strong dollar, Baxter's sales rose 14% in both the third quarter and the first nine months, to $1,494 million and $4,506 million. However, last week its share price was hit by news that the European drug regulatory agency has asked for further clinical data on its blood substitute, HemAssist.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.